Negative reactions are accumulating across the country to the Covid vaccine and now a woman’s death is being investigated by the CDC after she received the single-dose of the the Johnson & Johnson vaccine.
A statement from Virginia State Vaccination Coordinator Danny Avula confirmed that the Centers for Disease Control and Prevention is investigating the death which occurred in March for its potential link to the vaccine.
The Virginia death was reported to the CDC’s Vaccine Adverse Event Reporting System, Avula said.
Johnson & Johnson said on Tuesday that it would pause its clinical trials and delay the rollout of its shot in Europe until the probe in the U.S. was ironed out.
Federal health agencies on Tuesday called for a pause on administering the Johnson & Johnson vaccine to dig deeper into reports from six women between the ages of 18 and 48 who said they fell ill with a “a rare and severe type of blood clot” – as described by the CDC – within two weeks of receiving the vaccine. Only one woman has died so far.
Nearly 7 million doses of the vaccine have been administered in the U.S.
The CDC is set to convene a meeting on Wednesday to review the cases.
The pause is expected to be lifted in the near-future.
Johnson & Johnson assured in a statement that the health and safety of people who use its products is its number one priority.
CDC and FDA Urge Pause on J&J Vaccine After “Rare and Severe” Blood Clots Occurred
The Centers for Disease Control and Prevention (CDC) and the U.S. Food and Drug Administration (FDA) have issued a joint statement urging states to “pause” the use of the Johnson and Johnson COVID-19 vaccine after those who received it experienced severe blood clotting.
The statement reads, in part:
CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination.
The statement called the side effect “extremely rare” and said the CDC would convene a meeting of the Advisory Committee on Immunization Practices (ACIP) tomorrow to review the cases further. The FDA will review the CDC’s analysis and also plans to investigate the cases. “Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” reads the statement.
In the past week, administration of the Johnson and Johnson vaccine was halted at four different locations in Georgia, Colorado, Iowa and North Carolina after numerous adverse reactions, such as fainting and lightheadedness, occurred.
FDA Denies That Four Volunteers Developed Bell's Palsy From Pfizer's Covid-19 Vaccine Shot
According to U.S. regulators, four people that received Pfizer’s Covid-19 vaccine in a trial developed Bell’s palsy which causes temporary facial paralysis.
The Food and Drug Administration (FDA) said Bell’s palsy could not have been caused by the vaccine but doctors should keep track of anyone else who gets it going forward.
This isn’t the first time it’s been linked to vaccines, but scientists have ultimately ruled that shots did not trigger Bell’s in all but one case – a Swiss flu vaccine that was sold during the 2001-2002 flu season there, then promptly taken off the market.
So far, the FDA said that the number of Bell’s palsy cases seen in the Pfizer vaccine trial was ‘consistent with the background frequency of reported Bell’s palsy in the vaccine group that is consistent with the expected background rate in the general population, and there is no clear basis upon which to conclude a causal relationship at this time,’ but will keep a close watch on future cases.
The four cases of Bell’s palsy were the only side effect that the FDA saw as ‘imbalanced’ with more occurring in the vaccine group than the placebo group, and fewer than 0.5 percent of the trial participants had serious side effects.
Among the four people who developed Bell’s palsy, one saw facial paralysis or weakness within three days after they received the shot. But the participant’s face returned to normal about three days after that.
Although doctors are not sure exactly what causes Bell’s palsy, there are some factors that can leave someone more prone to getting it such as diabetes or an upper respiratory infection like the cold or flu.
They don’t believe that Pfizer’s vaccine is the cause of the issue but if given the green light to move forward, the FDA says Pfizer will be required to track data on future vaccine recipients if they develop temporary facial paralysis.
